Michael Martin Haglund

Michael Martin Haglund

Duke Surgery Distinguished Professor of Neurosurgery in the School of Medicine

My clinical areas of expertise include spinal surgery, especially cervical spine surgery where I have performed almost 8,300 cervical spine procedures and recently was ranked the top cervical spine surgeon in the country by MPIRICA (an analytical company that reviews surgical outcomes).  I believe the whole patient is important and we emphasize time with the patient and careful discussions regarding possible surgery. Our excellent results are due to a great team of physicians, nurses, CRNAs, and anesthesiologists.  I also believe in the spiritual side in taking care of my patients. As a design surgeon we are developing better ways to treat cervical spine disease through innovative approaches to the cervical spine.

Through my Masters in Academic Medicine degree, I developed the Surgical Autonomy Program which is now used in 7 Neurosurgery Programs across the country and is an innovative way to teach, assess, and provide feedback to residents in the intraoperative environment.  Over the last twelve years we have developed the first ever Division of Global Neurosurgery and Neurology (launched in 2014), where I serve as the Division Chief and the Division boasts over 100 members including faculty, graduate and medical students, undergraduate students and an outstanding staff of researchers, most located in the Duke Global Health Institute.  The Division has published over 120 manuscripts between 2014 and 2023.  We have primarily worked in building capacity, teaching, and collaborative research projects in Uganda.  In 2019 I was invited to join the faculty at the Duke-Singapore Global Health Institute and we are working with the Singapore Neuroscience Department to develop outreach and increase capacity in Jaffna, Sri Lanka.

Appointments and Affiliations

  • Duke Surgery Distinguished Professor of Neurosurgery in the School of Medicine
  • Professor of Neurosurgery
  • Professor in Orthopaedic Surgery
  • Research Professor of Global Health
  • Professor of Neurobiology

Contact Information

Education

  • M.Med.Sc. University of Southern California, 2016
  • Ph.D. University of Washington, 1988
  • M.D. University of Washington, 1987

Research Interests

-Cervical Spine Surgery
-Global Neurosurgery: Traumatic Brain Injury, Epilepsy

Awards, Honors, and Distinctions

  • Resident Advocate Award. Duke Neurosurgery Residents. 2019
  • University of Washington Alumni Humanitarian of Year. University of Washington Alumni Association. 2018
  • Duke University Alunmi Humanitarian of Year Award . Duke University Alumni Association. 2018
  • Resident Advocate of the Year. Residents in Department of Neurosurgery. 2017
  • Humanitarian of the Year. American Association of Neurological Surgeons. 2015
  • Velji Global Health Education Faculty Award. Consortium of Universities for Global Health. 2015
  • Triangle Business Journal Health Care Hero Award. Triangle Business Journal. 2014
  • Palumbo Duke University Teaching and Mentoring Award. Duke University. 2013
  • Distinguished Alumnus of the Year. Pacific Lutheran University. 2013
  • Endowed Chair, Distinguished Professor of Neurosurgery. Duke Department of Surgery, Duke University. 2012
  • Sloan Research Fellowship-Neuroscience. Alfred P. Sloan Foundation. 1996

Courses Taught

  • GLHLTH 395T: Bass Connections Global Health Research Team

In the News

Representative Publications

  • Babu, R; Thomas, S; Hazzard, MA; Lokhnygina, YV; Friedman, AH; Gottfried, ON; Isaacs, RE; Boakye, M; Patil, CG; Bagley, CA; Haglund, MM; Lad, SP, Morbidity, mortality, and health care costs for patients undergoing spine surgery following the ACGME resident duty-hour reform: Clinical article., J Neurosurg Spine, vol 21 no. 4 (2014), pp. 502-515 [10.3171/2014.5.SPINE13283] [abs].
  • Haglund, MM; Meno, JR; Hochman, DW; Ngai, AC; Winn, HR, Correlation of intrinsic optical signal, cerebral blood flow, and evoked potentials during activation of rat somatosensory cortex., J Neurosurg, vol 109 no. 4 (2008), pp. 654-663 [10.3171/JNS/2008/109/10/0654] [abs].
  • Haglund, MM; Hochman, DW, Imaging of intrinsic optical signals in primate cortex during epileptiform activity., Epilepsia, vol 48 Suppl 4 (2007), pp. 65-74 [10.1111/j.1528-1167.2007.01243.x] [abs].
  • Haglund, MM; Hochman, DW, Furosemide and mannitol suppression of epileptic activity in the human brain., J Neurophysiol, vol 94 no. 2 (2005), pp. 907-918 [10.1152/jn.00944.2004] [abs].
  • Haglund, MM; Hochman, DW, Optical imaging of epileptiform activity in human neocortex., Epilepsia, vol 45 Suppl 4 (2004), pp. 43-47 [10.1111/j.0013-9580.2004.04010.x] [abs].
  • Borel, CO; McKee, A; Parra, A; Haglund, MM; Solan, A; Prabhakar, V; Sheng, H; Warner, DS; Niklason, L, Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage., Stroke, vol 34 no. 2 (2003), pp. 427-433 [abs].
  • Muñana, KR; Vitek, SM; Tarver, WB; Saito, M; Skeen, TM; Sharp, NJH; Olby, NJ; Haglund, MM, Use of vagal nerve stimulation as a treatment for refractory epilepsy in dogs., J Am Vet Med Assoc, vol 221 no. 7 (2002), pp. 977-983 [10.2460/javma.2002.221.977] [abs].
  • Quinn, JA; Pluda, J; Dolan, ME; Delaney, S; Kaplan, R; Rich, JN; Friedman, AH; Reardon, DA; Sampson, JH; Colvin, OM; Haglund, MM; Pegg, AE; Moschel, RC; McLendon, RE; Provenzale, JM; Gururangan, S; Tourt-Uhlig, S; Herndon, JE; Bigner, DD; Friedman, HS, Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma., J Clin Oncol, vol 20 no. 9 (2002), pp. 2277-2283 [10.1200/JCO.2002.09.084] [abs].
  • Cerne, R; Haglund, MM, Electrophysiological correlates to the intrinsic optical signal in the rat neocortical slice., Neurosci Lett, vol 317 no. 3 (2002), pp. 147-150 [10.1016/s0304-3940(01)02453-3] [abs].
  • Friedman, HS; Pluda, J; Quinn, JA; Ewesuedo, RB; Long, L; Friedman, AH; Cokgor, I; Colvin, OM; Haglund, MM; Ashley, DM; Rich, JN; Sampson, J; Pegg, AE; Moschel, RC; McLendon, RE; Provenzale, JM; Stewart, ES; Tourt-Uhlig, S; Garcia-Turner, AM; Herndon, JE; Bigner, DD; Dolan, ME, Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma., J Clin Oncol, vol 18 no. 20 (2000), pp. 3522-3528 [10.1200/JCO.2000.18.20.3522] [abs].
  • Schwartz, TH; Haglund, MM; Lettich, E; Ojemann, GA, Asymmetry of neuronal activity during extracellular microelectrode recording from left and right human temporal lobe neocortex during rhyming and line-matching., J Cogn Neurosci, vol 12 no. 5 (2000), pp. 803-812 [10.1162/089892900562615] [abs].
  • McKhann, GM; Schoenfeld-McNeill, J; Born, DE; Haglund, MM; Ojemann, GA, Intraoperative hippocampal electrocorticography to predict the extent of hippocampal resection in temporal lobe epilepsy surgery., J Neurosurg, vol 93 no. 1 (2000), pp. 44-52 [10.3171/jns.2000.93.1.0044] [abs].
  • Macknik, SL; Martinez-Conde, S; Haglund, MM, The role of spatiotemporal edges in visibility and visual masking., Proc Natl Acad Sci U S A, vol 97 no. 13 (2000), pp. 7556-7560 [10.1073/pnas.110142097] [abs].
  • Macknik, SL; Haglund, MM, Optical images of visible and invisible percepts in the primary visual cortex of primates., Proc Natl Acad Sci U S A, vol 96 no. 26 (1999), pp. 15208-15210 [10.1073/pnas.96.26.15208] [abs].